Hair Relaxer Lawsuit — Frequently Asked Questions

The hair relaxer cancer lawsuit involves product liability claims against manufacturers of chemical hair relaxers and straighteners. Plaintiffs allege that these products — which contain endocrine-disrupting chemicals like formaldehyde, parabens, phthalates, and BPA — caused uterine cancer, ovarian cancer, endometriosis, and uterine fibroids. The NIH Sister Study (October 2022) found that frequent users had 2.55 times the risk of uterine cancer. Cases are consolidated in MDL 3060 in the Northern District of Illinois.

You may qualify if you: (1) used chemical hair relaxers or straighteners, especially frequently (more than 4 times per year) and over a long period; (2) have been diagnosed with uterine cancer, ovarian cancer, endometriosis, or uterine fibroids; and (3) are within your state's statute of limitations. Duration and frequency of use strengthen a claim. Women who used these products from childhood through adulthood are often strong candidates.

The primary qualifying conditions are: uterine cancer (endometrial cancer) — the strongest scientific link; ovarian cancer; endometriosis; and uterine fibroids. Breast cancer may also qualify — consult an attorney about your specific situation. A free case evaluation will help determine whether your specific diagnosis is covered.

MDL 3060 stands for Multidistrict Litigation No. 3060 — 'In Re: Hair Relaxer Marketing, Sales Practices and Products Liability Litigation.' It is a federal consolidation of thousands of hair relaxer cancer cases in the Northern District of Illinois before Judge Mary Rowland. MDL consolidation means pretrial proceedings (discovery, motions) are coordinated efficiently for all plaintiffs. Individual cases retain their own identity. As of 2026, over 11,000 cases have been filed. Daubert hearings are set for mid-2026.

No global settlement has been reached as of 2026. The litigation is still in active pre-trial phases. Bellwether trials, if they proceed, typically encourage settlement negotiations. Judge Rowland approved punitive damages in September 2024, which is significant for potential compensation. You can still file a claim — there is no deadline related to a settlement because none has occurred.

Filing deadlines (statutes of limitations) vary by state — typically 2 to 3 years for product liability claims. Critically, the 'discovery rule' means your deadline may start from when you discovered (or should have discovered) that your condition could be linked to hair relaxers. For many women, this was October 2022 when the NIH Sister Study was published. Do not assume your deadline has passed — consult an attorney who can evaluate your specific situation.

Yes. While knowing specific brands strengthens a claim, many women used multiple brands over many years and don't have records. Attorneys can work with your recollection, photos, family memories, and other circumstantial evidence. Don't let lack of exact brand knowledge stop you from seeking a free consultation.

Medical records confirming your diagnosis are important, but you do not need to have them in hand before submitting a free case review. Attorneys can help you gather the necessary documentation once they have evaluated your case. Your medical history, prescription records, and pathology reports from treatment all count.

Hair relaxer cancer cases are individual product liability lawsuits consolidated in MDL 3060 for pre-trial efficiency — they are NOT a class action. Each claimant maintains an individual case with individual damages based on her specific medical situation and losses. This is an important distinction: you are not sharing a lump sum with thousands of others, but pursuing individual compensation.

There is no upfront cost to file a hair relaxer cancer claim. Attorneys handling these cases work on a contingency fee basis — they only get paid if you receive compensation. The initial case evaluation is completely free. If you win a settlement or verdict, the attorney's fee (typically 33-40%) comes out of the recovery, not out of your pocket.